biotech · Presbyopia · Eye Diseases · LENZ
LENZ Therapeutics
LENZ Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- San Diego, USA
- Employees
- 176
- Programs
- 5
- Drugs
- 6
- Patents
- 20
LENZ Therapeutics clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to LENZ Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
LENZ Therapeutics trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for LENZ Therapeutics.
-
Aceclidine+tropicamide combination — Phase 2
Clinical update -
Aceclidine + Brimonidine — Phase 1
Clinical update -
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution — Phase 1
Clinical update -
Aceclidine+Brimonidine combination ophthalmic solution — Phase 3
Clinical update -
PRX-100 — Phase 2
Clinical update